The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

First approved in 1989, clozapine is the only medication indicated for treatment-resistant schizophrenia. It's also indicated ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

FDA Center for Drug Evaluation and Research acting director, said in a news release. The drug was tested in two randomized, double-blind, placebo- and active-controlled trials. It was given to ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and Research, said in a ...

Department of Health Technology Assessment, Shanghai Health Development Research Center (Shanghai Medical Information ... this research constructs a decision evaluation system for new drug pricing in ...

He was put on another drug, which had Health Canada's approval ... (Turgut Yeter/CBC) Stuart Edmonds, executive vice-president of mission, research and advocacy at the Canadian Cancer Society ...